TrialBreast cancer research and treatment2017

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.

S Alkner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.